Citigroup »

Protalix Biotherapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Protalix Biotherapeutics shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 2.5M 1.18
2023-09-30 $2.7M 2.5M 1.07
2023-03-31 $3.1M 2.5M 1.23
2022-12-31 $2.6M 2.5M 1.03
2022-09-30 $2.5M 2.5M 0.98
2021-12-31 $2.3M 2.5M 0.93

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Protalix Biotherapeutics

Highbridge Capital Management
Citigroup

View all funds holding Protalix Biotherapeutics